Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Melanoma: HELP
Articles by Ilaria Castagno
Based on 2 articles published since 2010
(Why 2 articles?)
||||

Between 2010 and 2020, I. Castagno wrote the following 2 articles about Melanoma.
 
+ Citations + Abstracts
1 Guideline Spitz/Reed nevi: proposal of management recommendations by the Dermoscopy Study Group of the Italian Society of Dermatology (SIDeMaST). 2014

Broganelli, P / Titli, S / Lallas, A / Alaibac M Annetta, A / Battarra, V / Brunetti, B / Castagno, I / Cavicchini, S / Ferrari, A / Ghigliotti, G / Landi, C / Manganoni, A / Moscarella, E / Pellacani, G / Pizzichetta, M A / Rosina, P / Rubegni, P / Satta, R / Scalvenzi, M / Stanganelli, I / Stinco, G / Zalaudek, I / Zampieri, P / Argenziano, G / Anonymous1420806. ·Department of Oncology and Hematology, Section of Dermatology, City of Health and Science Hospital of Turin, Turin, Italy - paolobroganelli@inwind.it. ·G Ital Dermatol Venereol · Pubmed #25213387.

ABSTRACT: -- No abstract --

2 Article The large spectrum of Spitzoid tumors: a retrospective survival study. 2019

Broganelli, Paolo / Ribero, Simone / Castagno, Ilaria / Ricceri, Fulvio / Deboli, Tommaso / Marra, Elena / Tomasini, Carlo / Sacerdote, Carlotta / Osella-Abate, Simona / Sanlorenzo, Martina / Quaglino, Pietro / Fierro, Maria T. ·Dermatologic Clinic Department of Medical Sciences, University of Turin, Turin, Italy. · Dermatologic Clinic Department of Medical Sciences, University of Turin, Turin, Italy - simone.ribero@unito.it. · Department of Oncology and Dermatology, City of Health and Science, University of Turin, Turin, Italy. · Unit of Cancer Epidemiology, Department of Medical Sciences, City of Health and Science, University of Turin, Turin, Italy. · Unit of Epidemiology, Regional Health Service ASLTO3, Grugliasco, Turin, Italy. · Department of Clinical-Surgical, Diagnostic and Pediatric Science, Institute of Dermatology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy. · Section of Surgical Pathology, Department of Medical Sciences, University of Turin, Turin, Italy. · Department of Medicinee I, Comprehensive Cancer Center, Institute of Cancer Research, Medical University of Vienna, Vienna, Austria. ·G Ital Dermatol Venereol · Pubmed #28704985.

ABSTRACT: BACKGROUND: There is no universally-accepted classification of Spitzoid tumors. This makes it difficult to assign a correct diagnosis and select a treatment that minimizes the risk of overestimating, or worse, underestimating, the malignant potential of these tumors. The aim of this study was to describe the clinical-pathological and epidemiological features of Spitzoid tumors, as well as to assess mortality in these patients. METHODS: This retrospective cohort study looked at data on Spitzoid tumors excised in 1999-2012 at the Dermatologic Clinic of the Turin University Hospital. Spitzoid melanoma specific survival curves were generated with the Kaplan-Meier method and compared using the log-rank test. RESULTS: In this time period, 1663 lesion were described at the pathologic report as Spitzoid. 262 (15.75%) were Spitz nevi, 307 (18.46%) Reed nevi, 827 (49.73%), 810 (48.71%) Spitzoid dysplastic nevi, 17(1.02%) atypical Spitzoid tumors, and 267 (16.06%) Spitzoid melanomas. Median follow-up time was 9 years. Out of the entire cohort only 24 patients died from melanoma. All of them received a diagnosis of Spitzoid melanoma. None of the patients with a diagnosis of not melanoma Spitz tumor died for melanoma during the follow-up. CONCLUSIONS: In the large majority of the cases, Spitz tumor should be considered as benign lesion and excised only if melanoma features are seen. The used clinical pathological classification avoid misdiagnoses, inappropriate treatment and the risk of death for melanoma.